CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $137.18M, lower than 95% of all stocks globally
- PositionGross margin is 15.1%, lower than 95% of its Diagnostics & Research peers (median 51.1%)
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
195.50BKRW137.18M · vs all stocks (USD)
Revenue (TTM)
53.50BKRW37.54M · vs all stocks (USD)
Profit Margin
-1.16%vs Diagnostics & Research peers
Beta
1.51xvs all stocks
52-Week Change
-35.91%vs all stocks
Market Capitalization
195.50BKRW137.18M · vs all stocks (USD)
Enterprise Value
312.07BKRW218.97M · vs all stocks (USD)
Price to Sales (TTM)
3.93xvs Diagnostics & Research peers
Price to Book (MRQ)
1.05xvs Diagnostics & Research peers
Enterprise to Revenue
5.83xvs Diagnostics & Research peers
Gross Margin
15.06%vs Diagnostics & Research peers
Profit Margin
-1.16%vs Diagnostics & Research peers
Operating Margin
-13.67%vs Diagnostics & Research peers
Return on Assets (TTM)
-1.87%vs Diagnostics & Research peers
Return on Equity (TTM)
-1.30%vs Diagnostics & Research peers
Revenue (TTM)
53.50BKRW37.54M · vs all stocks (USD)
Revenue per Share (TTM)
5.06KKRWUpdated Jul 14, 2026Quarterly Revenue Growth
-5.50%vs Diagnostics & Research peers
Gross Profit (TTM)
12.77BKRW8.96M · vs all stocks (USD)
EBITDA (TTM)
551.54MKRW387.00K · vs all stocks (USD)
Net Income (TTM)
-618.58MKRW-434.03K · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-5.50%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
874.25MKRW613.42K · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-8.92BKRW-6.26M · vs all stocks (USD)
5-Year Average Dividend Yield
0.12%vs all stocks
Payout Ratio
0.00%vs Diagnostics & Research peers
Minority Interest (Equity)
3.99BKRWFY2025 · Dec 31, 2025Revenue
165.52BKRWFY2025 · Dec 31, 2025Cost of Goods Sold
136.55BKRWFY2025 · Dec 31, 2025Gross Profit
28.97BKRWFY2025 · Dec 31, 2025Operating Income
-13.79BKRW-9.68M · vs all stocks (USD)
Pre-tax Income
-271.18BKRWFY2025 · Dec 31, 2025Income Tax Expense
2.34BKRWFY2025 · Dec 31, 2025Net Income
-273.53BKRWFY2025 · Dec 31, 2025EBIT
-266.42BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
-7.66BKRWFY2025 · Dec 31, 2025Research & Development
18.02BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
8.36BKRWFY2025 · Dec 31, 2025Other Operating Expenses
2.86BKRWFY2025 · Dec 31, 2025Non-operating Interest Income
568.52MKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
4.77BKRWFY2025 · Dec 31, 2025Net Income from Continuing Operations
-273.53BKRWFY2025 · Dec 31, 2025Minority Interests (P&L)
667.99MKRWFY2025 · Dec 31, 2025Operating Cash Flow
-268.23BKRWFY2025 · Dec 31, 2025Free Cash Flow
-269.27BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.46BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-273.53BKRWFY2025 · Dec 31, 2025Stock-based Compensation
121.42MKRWFY2025 · Dec 31, 2025Other Non-cash Items
4.26BKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-1.85BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
2.75BKRWFY2025 · Dec 31, 2025Capital Expenditures
-1.04BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-4.75BKRWFY2025 · Dec 31, 2025Net Acquisitions
149.22MKRWFY2025 · Dec 31, 2025Purchase of Investments
-2.00BKRWFY2025 · Dec 31, 2025Sale of Investments
2.23BKRWFY2025 · Dec 31, 2025Other Investing Activity
2.11BKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
1.45BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-28.10BKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-382.00MKRWFY2025 · Dec 31, 2025Net Financing Cash Flow
-28.48BKRWFY2025 · Dec 31, 2025Shares Outstanding
15.03MSharesUpdated Jul 14, 2026Float Shares
7.45MSharesUpdated Jul 14, 2026% Held by Insiders
42.71%vs all stocks
% Held by Institutions
2.54%vs all stocks
Total Cash (MRQ)
464.98MKRW326.26K · vs all stocks (USD)
Total Cash per Share (MRQ)
30.94KRWUpdated Jul 14, 2026Total Debt (MRQ)
97.13BKRW68.15M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5194xvs Diagnostics & Research peers
Current Ratio (MRQ)
3.21xvs Diagnostics & Research peers
Book Value per Share (MRQ)
12.44KKRWUpdated Jul 14, 2026Total Assets
303.69BKRW213.09M · vs all stocks (USD)
Total Current Assets
36.07BKRWFY2025 · Dec 31, 2025Total Liabilities
113.31BKRWFY2025 · Dec 31, 2025Total Non-current Assets
267.62BKRWFY2025 · Dec 31, 2025Total Non-current Liabilities
34.35BKRWFY2025 · Dec 31, 2025Total Current Liabilities
78.96BKRWFY2025 · Dec 31, 2025Cash
1.46BKRWFY2025 · Dec 31, 2025Cash Equivalents
-43.00KKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.46BKRWFY2025 · Dec 31, 2025Accounts Receivable
18.50BKRWFY2025 · Dec 31, 2025Inventory
6.92BKRWFY2025 · Dec 31, 2025Accounts Payable
4.79BKRWFY2025 · Dec 31, 2025Short-term Debt
57.74BKRWFY2025 · Dec 31, 2025Other Current Liabilities
130.00KRWFY2025 · Dec 31, 2025Long-term Debt
22.48BKRWFY2025 · Dec 31, 2025Other Non-current Liabilities
-470.00KRWFY2025 · Dec 31, 2025Common Stock (Book)
7.90BKRWFY2025 · Dec 31, 2025Retained Earnings
-39.01BKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
190.38BKRW133.58M · vs all stocks (USD)
Treasury Stock
77.67BKRWFY2025 · Dec 31, 202552-Week Low
12.43KKRWUpdated Jul 14, 202652-Week High
28.45KKRWUpdated Jul 14, 202652-Week Change
-35.91%vs all stocks
Beta
1.51xvs all stocks
50-Day MA
18.33KKRWUpdated Jul 14, 2026200-Day MA
22.65KKRWUpdated Jul 14, 2026Avg 10-Day Volume
41.80KSharesUpdated Jul 14, 2026Avg 30-Day Volume
50.31KSharesUpdated Jul 14, 2026Diluted EPS (TTM)
-18.16KKRWUpdated Jul 14, 20265 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Diagnostic
Goodwill-Heavy Asset Growth With a Recent Reversal
Assets grew over the long run on acquired goodwill, but have shrunk in each of four years.
Reads
Diagnostic
Goodwill-Heavy Equity
Equity looks heavy for the industry, but much of it is goodwill from past acquisitions.
Reads
Where is this company structurally exposed?
Diagnostic
Inverse RSI (1Y) Elevated With Four-Year Net Income And Gross Profit Decreases
The price reads stretched low, and net income and gross profit have fallen four years.
Reads
Diagnostic
Declining With Price Stretched Below 1Y Mean
The price sits well below its yearly mean, with net income and assets falling four years.
Reads
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 15.1%, lower than 95% of its Diagnostics & Research peers (median 51.1%)Significant
Gross margin: 0.15Industry median: 0.51Industry P5: 0.22Peers compared: 31.00
Structural Tensions
Looks liquid, but the distress score says otherwiseNotable
Current Ratio: 3.21Altman Z-Score: -1.66
Financial Health
Altman Z-Score -1.66: distress zoneCritical
Altman Z-Score: -1.66
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $137.18M, lower than 95% of all stocks globallySignificant
Market cap (USD): 137,176,708.24Global P5: 269,387,740.27
Companies that share the same coordination system — how they create, deliver, or capture value.
Great Rich Technologies Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
EnSilica Plc
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Livewire Group Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Solid State plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Iofina plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Cmes Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRisk
Hannong Chemicals Inc.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Skyx Platforms Corp
Tier 1ProductionThroughput-Bound ConversionRuleInterface
Tigo Energy Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Auros Technology Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Kunwu Jiuding Investment Holdings Co., Ltd.
3 interpretationsDown-Close Share With Multi-Year Earnings DecreaseDeclining With Price Stretched Below 1Y MeanInverse RSI (1Y) Elevated With Four-Year Net Income And Gross Profit Decreases
Wintao Communications Co.
2 interpretationsDown-Close Share With Multi-Year Earnings DecreaseInverse RSI (1Y) Elevated With Four-Year Net Income And Gross Profit Decreases
Wuhan Easydiagnosis Biomedicine Co., Ltd.
2 interpretationsDown-Close Share With Multi-Year Earnings DecreaseDeclining With Price Stretched Below 1Y Mean